Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-individual randomized comparison of gadobutrol vs gadoterate meglumine in breast MRI
2009-013432-20Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of gadobutrol and gadoterate meglumine in breast cancer and breast neoplasia (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Peak enhancement at 1 minute after contrast application. Started Jun 2009; status: completed.
02
Drugs
gadobutrolgadoterate meglumine
03
Conditions
breast cancerbreast neoplasia
Beyond the preview
Go deeper on 2009-013432-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013432-20.